Zeria Pharmaceutical Co Ltd (4559)

Tokyo

Currency in JPY

2,029.0

+5.0(+0.25%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

2,021.0

2,048.0

52 wk Range

1,972.0

2,505.0

4559 Income Statement

Featured here, the Income Statement (earnings report) for Zeria Pharmaceutical Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

Total Revenues

aa.aa

55,442

59,532

68,383

75,725

87,311

Total Revenues Growth

aa.aa

-8.25%

+7.38%

+14.87%

+10.74%

+15.3%

Cost Of Revenues

aa.aa

15,807

17,384

18,895

20,224

23,351

Gross Profit

aa.aa

39,635

42,148

49,488

55,501

63,960

Gross Profit Growth

aa.aa

-9.49%

+6.34%

+17.41%

+12.15%

+15.24%

Gross Profit Margin %

aa.aa

71.49%

70.8%

72.37%

73.29%

73.26%

Other Operating Expenses, Total

aa.aa

36,192

35,782

40,473

45,879

51,762

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-9.02%	-1.13%	+13.11%	+13.36%	+12.82%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,411	4,789	3,456	3,726	4,106
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	30,781	30,993	32,646	36,834	41,806
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

3,443

6,366

9,015

9,622

12,198

Operating Income Growth

aa.aa

-14.12%

+84.9%

+41.61%

+6.73%

+26.77%

EBIT Margin %

aa.aa

6.21%

10.69%

13.18%

12.71%

13.97%

Net Interest Expenses

aa.aa

-106

-41

-19

171

Net Interest Expenses Growth

aa.aa

+168%

-723.53%

+61.32%

+53.66%

+1,000%

Interest Expense, Total

aa.aa

-238

-315

-337

-457

-452

Interest And Investment Income

aa.aa

255

209

296

438

623

Other Non Operating Expenses, Total

aa.aa

-287

-327

-1,397

-1,091

471

EBT, Excl. Unusual Items

aa.aa

3,173

5,933

7,577

8,512

12,840

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

373

-230

-327

495

-17

EBT, Incl. Unusual Items

aa.aa

3,921

5,720

7,270

9,508

12,617

EBT, Incl. Unusual Items Growth

aa.aa

+0.05%

+45.88%

+27.1%

+30.78%

+32.7%

EBT, Incl. Unusual Items Margin

aa.aa

7.07%

9.61%

10.63%

12.56%

14.45%

Income Tax Expense

aa.aa

791

1,746

1,065

1,813

2,650

Net Income to Company

aa.aa

3,130

3,974

6,205

7,695

9,967

Minority Interest

aa.aa

-11

-13

-10

-31

Net Income

aa.aa

3,119

3,961

6,195

7,731

9,936

Net Income Growth

aa.aa

+6.63%

+27%

+56.4%

+24.79%

+28.52%

Net Income Margin %

aa.aa

5.63%

6.65%

9.06%

10.21%

11.38%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

3,119

3,961

6,195

7,731

9,936

Basic EPS - Continuing Operations

aa.aa

67.7

87.75

140.24

175.39

225.41

Basic EPS - Continuing Operations Growth

aa.aa

+8.12%

+29.62%

+59.82%

+25.06%

+28.52%

Diluted EPS - Continuing Operations

aa.aa

67.7

87.75

140.24

175.39

225.41

Diluted EPS - Continuing Operations Growth

aa.aa

+8.12%

+29.62%

+59.82%

+25.06%

+28.52%

Basic Weighted Average Shares Outstanding

aa.aa

46.07

45.14

44.17

44.08

Diluted Weighted Average Shares Outstanding

aa.aa

46.07

45.14

44.17

44.08

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

+2.94%

+14.29%

+10%

+6.82%

EBITDA

aa.aa

7,878

11,765

15,163

17,177

19,752

EBITDA Growth

aa.aa

-0.93%

+49.34%

+28.88%

+13.28%

+14.99%

EBITDA Margin %

aa.aa

14.21%

19.76%

22.17%

22.68%

22.62%

EBIT

aa.aa

3,443

6,366

9,015

9,622

12,198

* In Millions of JPY (except for per share items)

NSE 30

5,318.15

-11.58

-0.22%

NSE All Share

145,882.75

-65.72

-0.05%

US 30

43,978.00

+2.1

0.00%

US 500

6,373.40

-0.1

0.00%

FTSE 100

9,135.75

+6.04

+0.07%

DAX

23,949.43

-122.91

-0.51%

South Africa Top 40

93,607.62

+324.95

+0.35%

Market Movers

Name	Last	Chg. %	Vol.
Lasaco Assurance PLC	4.49	+8.45%	84.43M
Access Holdings	27.60	-0.36%	22.85M
Ellah Lakes	16.06	+10.00%	20.28M
Nigerian Breweries	70.00	-5.91%	13.32M
Guaranty Trust Holding	99.10	-0.75%	9.17M
UBA	48.25	+0.31%	7.49M
Aradel Holdings	519.70	-0.06%	829.73K

Name	Last	Chg. %	Vol.
Prestige	2.20	+10.00%	6.14M
Champion Brew	17.38	+10.00%	3.88M
Mansard Ins	17.710	+10.00%	3.20M
Initiates	14.52	+10.00%	2.17M
SCOA Nigeria	6.050	+10.00%	41.46K
Airtel Africa	2,541.50	+10.00%	478.00
Ellah Lakes	16.06	+10.00%	20.28M

Name	Last	Chg. %	Vol.
Juli	9.00	-10.00%	100.19K
Geregu Power	1,027.40	-10.00%	1.80K
Transcorp Power	257.90	-9.98%	19.22K
Conoil	211.10	-9.98%	16.93K
Eunisell Interlinked	21.200	-9.79%	42.32K
Chellarams	9.50	-9.52%	25.23K
Unilever Nigeria	72.05	-9.03%	107.72K

Trending Stocks

Name	Last	Chg. %	Vol.
Aiico	4.23	+9.87%	37.19M
Ellah Lakes	16.06	+10.00%	20.28M
VFD PLC	12.20	+0.83%	4.56M
Linkassure	2.48	+9.73%	11.46M
Access Holdings	27.60	-0.36%	22.85M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aa Aaa	5,649.80	+45.05%	8,195.03
Aaa Aa	540.00	+41.25%	762.75
Aaaaa A Aaa A	1,890.00	+27.55%	2,410.69
Aa Aaaaaaaaa	159.60	+23.56%	197.20
Aaaaaaaa A	70.90	+21.64%	86.24
Aaaa Aaaaaa	640.00	+16.46%	745.34

Name	Last	Upside	Fair Value
Aaaaa Aa Aaa	5,649.80	+45.05%	8,195.03
Aaa Aa	540.00	+41.25%	762.75
Aaaaa A Aaa A	1,890.00	+27.55%	2,410.69
Aa Aaaaaaaaa	159.60	+23.56%	197.20
Aaaaaaaa A	70.90	+21.64%	86.24
Aaaa Aaaaaa	640.00	+16.46%	745.34

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Zeria Pharmaceutical Co Ltd (4559)

4559 Income Statement

Trending Stocks